Skip to main content

Table 5 The relative hazards of idiopathic cardiomyopathy (ICD9 = 425.4; ICD10 = I42.0) in the diabetic and control groups (Fine and Gray's method)

From: Incidence of idiopathic cardiomyopathy in patients with type 2 diabetes in Taiwan: age, sex, and urbanization status-stratified analysis

 

Crude HR

Adjusted HRa

General characteristics

 Type 2 diabetes

1.96 (1.79–2.14)

1.60 (1.45–1.77)

 Age

  < 45

1.0

1.0

  45–64

1.23 (1.08–1.41)

0.99 (0.87–1.14)

  > 64

2.03 (1.77–2.32)

1.32 (1.13–1.53)

 Sex

  Female

1.0

1.0

  Male

1.34 (1.23–1.46)

1.42 (1.30–1.55)

 Urbanization status

  Urban area

1.0

1.0

  Rural area

1.38 (1.26–1.5)

1.22 (1.12–1.34)

 Comorbidities

  Ischemic heart disease

6.54 (6.01–7.12)

4.60 (4.13–5.12)

  Hypertensive disease

2.18 (2–2.37)

0.86 (0.75–0.99)

  Rheumatic heart disease

9.02 (7.77–10.47)

2.41 (2.03–2.86)

  Valvular heart disease

6.68 (6.03–7.41)

2.94 (2.59–3.34)

  Congenital heart disease

4.83 (3.48–6.72)

2.03 (1.45–2.85)

  Acute myocarditis

22.75 (11.9–43.48)

7.81 (3.91–15.6)

  Obesity

1.12 (0.84–1.51)

1.06 (0.78–1.42)

  Stroke

1.43 (1.29–1.58)

0.74 (0.66–0.82)

  Hyperlipidemia

1.14 (1.05–1.24)

0.60 (0.55–0.66)

 Antihypertensive medication

  β-Blocker

3.34 (3.06–3.63)

1.70 (1.54–1.88)

  ACEi

3.47 (3.18–3.78)

2.01 (1.80–2.25)

  ARBs

2.43 (2.23–2.64)

1.26 (1.11–1.43)

  1. ACEi angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, HR hazard ratio
  2. aBased on Cox proportional hazard regression with adjustment for age, sex, and urbanization status; status of ischemic heart disease, hypertensive disease, rheumatic heart disease, valvular heart disease, congenital heart disease, acute myocarditis, stroke, obesity, and hyperlipidemia; and antihypertensive medications use